Other authors suggested that tumor favoring effects of IL-17 may occur via an increase in suppressive functions of myeloid-derived suppressor cells (MDSCs) through the CXCL1/5–CXCR2 axis. This evidence concerns the gene CXCR2 and neoplasm.